Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2017
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma
Teresa M Petrella, Caroline Robert, Erika Richtig, et al.
Journal for Immunotherapy of Cancer
|
October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi, Kristen Spencer, Mary Ruisi, et al.
The Oncologist
|
May 20, 2015
A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Ryan J Sullivan, Nageatte Ibrahim, Donald P Lawrence, et al.
Cancer Immunology Research
|
April 5, 2017
Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients
Marlene Garcia-Neuer, Melina E Marmarelis, Sushrut R Jangi, et al.
Cancer Chemotherapy and Pharmacology
|
November 25, 2014
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Anthony W Tolcher, Amita Patnaik, Kyriakos P Papadopoulos, et al.
British Journal of Cancer
|
September 12, 2018
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006
Omid Hamid, Caroline Robert, Antoni Ribas, et al.
Cancer
|
March 1, 2014
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors
Allison Ackerman, Oliver Klein, David F McDermott, et al.
Radiation Oncology (London, England)
|
June 24, 2014
The role of whole brain radiation therapy in the management of melanoma brain metastases
Michael A Dyer, Nils D Arvold, Yu-Hui Chen, et al.
Pigment Cell & Melanoma Research
|
August 3, 2016
Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation
Benjamin Izar, Cailin E Joyce, Stephanie Goff, et al.
Melanoma Research
|
September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
Shalin Shah, Jason J Luke, Heather A Jacene, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2017
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma
Teresa M Petrella, Caroline Robert, Erika Richtig, et al.
Journal for Immunotherapy of Cancer
|
October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi, Kristen Spencer, Mary Ruisi, et al.
The Oncologist
|
May 20, 2015
A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Ryan J Sullivan, Nageatte Ibrahim, Donald P Lawrence, et al.
Cancer Immunology Research
|
April 5, 2017
Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients
Marlene Garcia-Neuer, Melina E Marmarelis, Sushrut R Jangi, et al.
Cancer Chemotherapy and Pharmacology
|
November 25, 2014
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Anthony W Tolcher, Amita Patnaik, Kyriakos P Papadopoulos, et al.
British Journal of Cancer
|
September 12, 2018
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006
Omid Hamid, Caroline Robert, Antoni Ribas, et al.
Cancer
|
March 1, 2014
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors
Allison Ackerman, Oliver Klein, David F McDermott, et al.
Radiation Oncology (London, England)
|
June 24, 2014
The role of whole brain radiation therapy in the management of melanoma brain metastases
Michael A Dyer, Nils D Arvold, Yu-Hui Chen, et al.
Pigment Cell & Melanoma Research
|
August 3, 2016
Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation
Benjamin Izar, Cailin E Joyce, Stephanie Goff, et al.
Melanoma Research
|
September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
Shalin Shah, Jason J Luke, Heather A Jacene, et al.
Page
of 6